Online Inquiry

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

  • Verification code
    Click image to refresh the verification code.

GTOnco™ Immuno-Oncology Assay Services

GTOnco™ Immuno-Oncology Assay Services

With professional service and various advanced equipment at Creative Biolabs, GTOnco™ platform provides high-quality preclinical profiling and monitoring of immune responses for the gene therapy-based I-O drug development. Utilizing the most effective combination of assays available to identify promising I-O therapeutics, our broad range of well-established assays and animal models allow clients to choose the most appropriate study design and screening method to identify the best option and optimize lead candidates. GTOnco™ platform allows you to rapidly identify single agent or combinations that affect tumor cell lysis, T cell proliferation and polarization, and natural killer (NK) cell function.

GTOnco™ I-O Assays for In Vitro Study

It is necessary to collect sufficient product characterization data for clinical development. Creative Biolabs has leveraged the cutting-edge technologies to build a groundbreaking platform for in vitro immune responses analysis of gene therapy-based I-O agents, including immune system activation study (T and B cells, natural killer cells, macrophages, and dendritic cells, as well as tumor cells) and immune cell-mediated anti-tumor effect study, etc. Multiple approaches have been developed and assessed by enzyme-linked immunosorbent assay (ELISA) and/or western blot and/or qPCR and/or flow cytometry and/or other methods of assessment.

GTOnco™ I-O Assays for In Vivo Study

Various robust animal models and assay systems have been successfully established at GTOnco™ platform to greatly facilitate the in vivo studies of gene therapy-based I-O products with less time and cost. In order to provide a model system that enables researchers to study the immune system and assess the immune cell-mediated anti-tumor response of I-O agents, syngeneic mouse tumor models with fully immune-competent hosts and humanized mouse models (HIS) have been developed in-house. We offer a variety of effective syngeneic cell line derived models for your research on I-O drug discovery in gene therapy. We also provide multiplex technologies such as flow cytometry, RT-qPCR, and ELISpot, immunohistochemistry or immunohistofluorescence-based imaging to analyze anti-tumor immune response profiling. Our experienced scientists are able to help you design the best assays for customized in vivo studies.

Creative Biolabs is specialized in gene therapy-based I-O drugs development and capable of designing and developing custom assay services to greatly accelerate your drug discovery process and expedite their IND application. With the in-depth scientific and technical expertise, we will be your best partner in the gene therapy-based I-O drugs development field. Please feel free to contact us by E-mail for a quote and further discussion with our scientists. Looking forward to cooperating with you.


  1. Pérez, P.; et al. (2018). A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice. Scientific Reports, 8(1).
  2. Yu, F.; et al. (2014). T-cell Engager-armed Oncolytic Vaccinia Virus Significantly Enhances Antitumor Therapy. Molecular Therapy, 22(1), pp.102-111.
  3. Velcheti, V. and Schalper, K. (2016). Basic Overview of Current Immunotherapy Approaches in Cancer. American Society of Clinical Oncology Educational Book, (36), pp.298-308.

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Interested in our expertise?

Contact us for more information

Get free consultations


  • Tel:
  • Email:


Easy access to products and services you need from our library via powerful searching tools

Enter your email here to subscribe.


Follow us on

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Copyright © 2021 Creative Biolabs. All Rights Reserved.